Date:10/4/2011

br/>Figure 5-10: CSF Management Market Drivers and Limiters, U.S., 2006 – 2016.. 93
Figure 5-11: Leading Competitors in the Pressure Adjustable Shunt Market, U.S.,
2009 ... 95
Figure 5-12: Leading Competitors in the Fixed Pressure Shunt Market, U.S.,
2009 ... 98
Figure 5-13: Leading Competitors in the Drainage Systems Market, U.S., 2009 . 100
Figure 5-14: Leading Competitors in the Total CSF Market, U.S., 2009 .. 103
INTRACRANIAL PRESSURE MONITORING DEVICE MARKET . 105
Figure 6-1: Total Intracranial Pressure Monitoring System Market by Type, U.S.,
2006 – 2016.... 110
Figure 6-2: Total ICP Transducer System Market, U.S., 2006 – 2016 . 113
Figure 6-3: Internal ICP Transducer Market, U.S., 2006 – 2016 .. 116
Figure 6-4: ICP External Transducer System Market, U.S., 2006 – 2016.. 119
Figure 6-5: Basic ICP Monitor Market, U.S., 2006 – 2016 . 122
Figure 6-6: Advanced ICP Monitor Market, U.S., 2006 – 2016.... 125
Figure 6-7: Intracranial Pressure Monitoring Device Market Leaders, U.S.,
2009 . 129
Figure 6-8: ICP Internal Transducer System Market Leaders, U.S., 2009 . 131
Figure 6-9: External Transducer System Market Leaders, U.S., 2009 134
DETACHABLE COIL MARKET. 136
Figure 7-1: Total Detachable Coil Market, U.S., 2006 – 2016. 138
Figure 7-2: Detachable Coil Market Value by Type, U.S., 2006 – 2016 ... 141
Figure 7-3: Detachable Coil Units Sold by Type, U.S., 2006 – 2016 . 143
Figure 7-4: Bare Platinum Coil Market, U.S., 2006 – 2016. 145
Figure 7-5: Coated Coil Market, U.S., 2006 – 2016 148
Figure 7-6: Detachable Coils Market Drivers and Limiters, U.S., 2009 .... 152
Figure 7-7: Leading Competitors in the Detachable Coils Market, U.S., 2009 .... 154
LIQUID EMBOLICS.. 155
Figure 8-1: Liquid Embolics Market, U.S., 2006 – 2016 156
Figure 8-2: Liquid Embolics Market, U.S., 2006 – 20
'/>"/>

SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine technology :

1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)